Functional differences between PD-1(+) and PD-1(-) CD4(+) effector T cells in healthy donors and patients with glioblastoma multiforme

Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) have been highly successful in the treatment of cancer. While PD-1 expression has been widely investigated, its role in CD4(+) effector T cells in the setting of health and cancer remains unclear, particularly in the setti...

Descripción completa

Detalles Bibliográficos
Autores principales: Goods, Brittany A., Hernandez, Amanda L., Lowther, Daniel E., Lucca, Liliana E., Lerner, Benjamin A., Gunel, Murat, Raddassi, Khadir, Coric, Vlad, Hafler, David A., Love, J. Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589094/
https://www.ncbi.nlm.nih.gov/pubmed/28880903
http://dx.doi.org/10.1371/journal.pone.0181538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589094/
https://www.ncbi.nlm.nih.gov/pubmed/28880903
http://dx.doi.org/10.1371/journal.pone.0181538

Ejemplares similares